FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387669675> ?p ?o ?g. }

• W4387669675 abstract "In the coronavirus efficacy (COVE) phase 3 efficacy trial of the mRNA-1273 vaccine, IgG binding antibody (bAb) concentration against Spike (BA.1 strain) and neutralizing antibody (nAb) titer against Spike (BA.1 strain) pseudovirus were assessed as correlates of risk of Omicron COVID-19 and as correlates of relative boost efficacy in per-protocol recipients of a third (booster) dose. Markers were measured on the day of the boost (BD1) and 28 days later (BD29). For SARS-CoV-2 naive individuals, BD29 Spike IgG-BA.1 strain bAbs and BD29 BA.1-strain nAbs inversely correlated with Omicron COVID-19: hazard ratio (HR) per 10-fold marker increase [95% confidence interval (CI)] = 0.16 (0.03, 0.79); P=0.024 and 0.31 (0.10, 0.96); P = 0.042, respectively. These markers also inversely correlated with Omicron COVID-19 in non-naive individuals: HR = 0.15 (0.04, 0.63); P = 0.009 and 0.28 (0.07, 1.08); P = 0.06, trend. Fold-rise in markers from BD1 to BD29 had similarly strong inverse correlations. For SARS-CoV-2 naive individuals, overall booster relative (three-dose vs two-dose) efficacy was 46% (95% CI: 20%, 64%) and correlated with BA.1 strain nAb titer at exposure. At 56, 251, and 891 arbitrary units (AU)/ml (10th, 50th, and 90th percentile), the booster relative efficacies were -8% (95% CI: -126%, 48%), 50% (25%, 67%), and 74% (49%, 87%), respectively. Similar relationships were observed for Spike IgG-BA.1 strain bAbs and for the markers measured at BD29. The performance of bAb and nAb markers as correlates of protection against Omicron COVID-19 supports their continued use as surrogate endpoints for mRNA vaccination against Omicron COVID-19." @default.
• W4387669675 created "2023-10-17" @default.
• W4387669675 creator A5000157109 @default.
• W4387669675 creator A5000243107 @default.
• W4387669675 creator A5001450693 @default.
• W4387669675 creator A5002540504 @default.
• W4387669675 creator A5007289352 @default.
• W4387669675 creator A5009227700 @default.
• W4387669675 creator A5011395355 @default.
• W4387669675 creator A5011877804 @default.
• W4387669675 creator A5019357485 @default.
• W4387669675 creator A5020230187 @default.
• W4387669675 creator A5021959335 @default.
• W4387669675 creator A5025421448 @default.
• W4387669675 creator A5028172291 @default.
• W4387669675 creator A5029754572 @default.
• W4387669675 creator A5039143154 @default.
• W4387669675 creator A5039529693 @default.
• W4387669675 creator A5044042152 @default.
• W4387669675 creator A5047194420 @default.
• W4387669675 creator A5049794472 @default.
• W4387669675 creator A5050864343 @default.
• W4387669675 creator A5051550648 @default.
• W4387669675 creator A5051696264 @default.
• W4387669675 creator A5053577218 @default.
• W4387669675 creator A5056611428 @default.
• W4387669675 creator A5064259175 @default.
• W4387669675 creator A5065246955 @default.
• W4387669675 creator A5067647063 @default.
• W4387669675 creator A5069748200 @default.
• W4387669675 creator A5075731113 @default.
• W4387669675 creator A5079509349 @default.
• W4387669675 creator A5083172043 @default.
• W4387669675 creator A5085731242 @default.
• W4387669675 creator A5085762412 @default.
• W4387669675 creator A5088316297 @default.
• W4387669675 creator A5090270861 @default.
• W4387669675 creator A5091029647 @default.
• W4387669675 date "2023-10-15" @default.
• W4387669675 modified "2023-10-17" @default.
• W4387669675 title "Omicron COVID-19 Immune Correlates Analysis of a Third Dose of mRNA-1273 in the COVE Trial" @default.
• W4387669675 doi "https://doi.org/10.1101/2023.10.15.23295628" @default.
• W4387669675 hasPublicationYear "2023" @default.
• W4387669675 type Work @default.
• W4387669675 citedByCount "0" @default.
• W4387669675 crossrefType "posted-content" @default.
• W4387669675 hasAuthorship W4387669675A5000157109 @default.
• W4387669675 hasAuthorship W4387669675A5000243107 @default.
• W4387669675 hasAuthorship W4387669675A5001450693 @default.
• W4387669675 hasAuthorship W4387669675A5002540504 @default.
• W4387669675 hasAuthorship W4387669675A5007289352 @default.
• W4387669675 hasAuthorship W4387669675A5009227700 @default.
• W4387669675 hasAuthorship W4387669675A5011395355 @default.
• W4387669675 hasAuthorship W4387669675A5011877804 @default.
• W4387669675 hasAuthorship W4387669675A5019357485 @default.
• W4387669675 hasAuthorship W4387669675A5020230187 @default.
• W4387669675 hasAuthorship W4387669675A5021959335 @default.
• W4387669675 hasAuthorship W4387669675A5025421448 @default.
• W4387669675 hasAuthorship W4387669675A5028172291 @default.
• W4387669675 hasAuthorship W4387669675A5029754572 @default.
• W4387669675 hasAuthorship W4387669675A5039143154 @default.
• W4387669675 hasAuthorship W4387669675A5039529693 @default.
• W4387669675 hasAuthorship W4387669675A5044042152 @default.
• W4387669675 hasAuthorship W4387669675A5047194420 @default.
• W4387669675 hasAuthorship W4387669675A5049794472 @default.
• W4387669675 hasAuthorship W4387669675A5050864343 @default.
• W4387669675 hasAuthorship W4387669675A5051550648 @default.
• W4387669675 hasAuthorship W4387669675A5051696264 @default.
• W4387669675 hasAuthorship W4387669675A5053577218 @default.
• W4387669675 hasAuthorship W4387669675A5056611428 @default.
• W4387669675 hasAuthorship W4387669675A5064259175 @default.
• W4387669675 hasAuthorship W4387669675A5065246955 @default.
• W4387669675 hasAuthorship W4387669675A5067647063 @default.
• W4387669675 hasAuthorship W4387669675A5069748200 @default.
• W4387669675 hasAuthorship W4387669675A5075731113 @default.
• W4387669675 hasAuthorship W4387669675A5079509349 @default.
• W4387669675 hasAuthorship W4387669675A5083172043 @default.
• W4387669675 hasAuthorship W4387669675A5085731242 @default.
• W4387669675 hasAuthorship W4387669675A5085762412 @default.
• W4387669675 hasAuthorship W4387669675A5088316297 @default.
• W4387669675 hasAuthorship W4387669675A5090270861 @default.
• W4387669675 hasAuthorship W4387669675A5091029647 @default.
• W4387669675 hasBestOaLocation W43876696751 @default.
• W4387669675 hasConcept C126322002 @default.
• W4387669675 hasConcept C159654299 @default.
• W4387669675 hasConcept C203014093 @default.
• W4387669675 hasConcept C207103383 @default.
• W4387669675 hasConcept C2778022156 @default.
• W4387669675 hasConcept C2779134260 @default.
• W4387669675 hasConcept C2779261636 @default.
• W4387669675 hasConcept C3008058167 @default.
• W4387669675 hasConcept C32611913 @default.
• W4387669675 hasConcept C44249647 @default.
• W4387669675 hasConcept C524204448 @default.
• W4387669675 hasConcept C71924100 @default.
• W4387669675 hasConcept C90924648 @default.
• W4387669675 hasConceptScore W4387669675C126322002 @default.
• W4387669675 hasConceptScore W4387669675C159654299 @default.
• W4387669675 hasConceptScore W4387669675C203014093 @default.
• W4387669675 hasConceptScore W4387669675C207103383 @default.

• next